Article

Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA.
Preventive Medicine (Impact Factor: 2.93). 12/2008; 48(5):426-31. DOI: 10.1016/j.ypmed.2008.11.010
Source: PubMed

ABSTRACT To report awareness of human papillomavirus (HPV) and HPV vaccine among women aged 18-49 years and, for recommended women aged 18-26 years, estimate initiation of HPV vaccination and describe factors associated with vaccination initiation among a national sample.
Data were analyzed from the National Immunization Survey-Adult, a nationally representative telephone survey conducted May-August 2007. Questions were asked about awareness of HPV and HPV vaccine and vaccine receipt.
A total of 1102 women aged 18-49 years were interviewed, 168 were aged 18-26 years. Overall, awareness of HPV (84.3%) and of HPV vaccine (78.9%) were high. Among women 18-26 years of age, vaccination initiation (> or =1 dose) was 10%. Factors associated with vaccination included not being married, living > or =200% of the federal poverty index, having health insurance, and vaccination with hepatitis B vaccine. HPV vaccination initiation among women aged 27-49 years was 1%.
Awareness of HPV and HPV vaccine were high. Two to 5 months after national HPV vaccination recommendations were published, one in ten women 18-26 years old had initiated the HPV vaccine series. Women at a higher socio-economic level were more likely to receive the vaccination. Vaccination initiation and completion will likely increase over the next years. Monitoring uptake is important to identify sub-groups that may not be receiving the vaccination.

0 Followers
 · 
116 Views
  • Source
    • "d Calculated as the total number of annual cases attributed to HPV divided by the total number of anogenital cases per year. who had received one dose and were eligible to complete the series, 73.2% received all three doses [6] [7] [8] [9]. In Israel, private vaccination coverage rates remain low, at around 10% of eligible women. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Barriers to human papillomavirus (HPV) vaccine acceptability in Israel include Israel's relatively low incidence of cervical cancer; the religiously-based 80% circumcision rate in Israel, which is regarded as contributing to the lower incidence of HPV infection in the country; the fact that HPV vaccine provides immunity against only few virus types; the vaccine's high cost; and the perception that HPV transmission is associated with unacceptable sexual relations. A recent survey has demonstrated that, following media two campaigns, Israeli's level of awareness of the vaccine increased but the actual vaccination rate remained low, at approximately 10%. Survey findings also indicated that an enduring barrier to HPV vaccination is the vaccine's high cost. Recent research on a convenience sample of Israeli undergraduate women 21 to 24 years of age showed that intentions to receive HPV vaccination in the coming year were a function of women's attitudes towards getting vaccinated and their perceptions of social support for doing so. Undergraduate women who intended to be vaccinated perceived the prevention of cervical cancer, avoidance of personal health threat, and avoidance of HPV infection per se to be the advantages of undergoing HPV vaccination. Disadvantages of getting vaccinated included fear of vaccine side effects, cost of the vaccine, and newness of the vaccine, doubts about vaccines, time required to undergo multiple vaccinations, and dislike of injections. Friends', mothers' and physicians' recommendations influenced women's intentions to be vaccinated in the coming year as well. This article forms part of a regional report entitled "Comprehensive Control of HPV Infections and Related Diseases in Israel" Vaccine Volume 31, Supplement 8, 2013. Updates of the progress in the field are presented in a separate monograph entitled "Comprehensive Control of HPV Infections and Related Diseases" Vaccine Volume 30, Supplement 5, 2012.
    Vaccine 11/2013; 31S8:I53-I57. DOI:10.1016/j.vaccine.2013.06.107 · 3.49 Impact Factor
  • Source
    • "Researchers have documented an increased awareness of HPV and HPV vaccine among college-aged women since the first HPV vaccine was released [8] [9] [10]. Three studies conducted among college students reported that 78.5–94.0% of college women had heard about HPV through various sources, especially from television and radio [9] [30] [37]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVES: This cross-sectional study, guided by Ajzen's Theory of Planned Behavior, aimed to identify factors that influence the decision to obtain an HPV vaccine among college women and to examine the relationships among these factors. METHODS: An electronic self-administered survey was utilized to collect data. An email invitation was sent to 3074 college women attending a large, public university in southern California, aged between 18 and 26 years. The email directed the recipient to click on a link to a web-based survey if she wanted to participate in the study. RESULTS: Participants in this study were college women (n=384; 175 HPV non-vaccinees and 209 HPV vaccinees). Women in this study knew that a Pap test is still needed after HPV vaccination and that the HPV vaccine does not protect against other Sexually Transmitted Infections. Both non-vaccinees and vaccinees had positive attitudes about mandating HPV vaccine. Knowledge and attitudes toward the vaccine were not directly linked to the outcome predictors - intention to obtain the vaccine and vaccine uptake. Attitude about receiving HPV vaccine, subjective norms (complying with the expectations of others), and perceived behavioral control were correlated with the outcome predictors. Subjective norms consistently predicted intention to obtain HPV vaccine and vaccine uptake. CONCLUSIONS: A proposal to mandate the HPV vaccine among young girls/women was acceptable to this population. Vaccination promotion strategies to increase the vaccine uptake rate among the catch-up group (aged 13-26) should include attention to college women's subjective norms. Health care provider's recommendation and encouragement from significant others (i.e., mother and peers) are critical in order for the college women to obtain the vaccine.
    Vaccine 01/2013; 31(10). DOI:10.1016/j.vaccine.2013.01.001 · 3.49 Impact Factor
  • Source
    • "Household income was indexed by self-reported FSME with individuals classified as 'eligible' or 'not eligible' for free school meals. Participants' awareness of HPV was assessed using the question 'Before today, had you heard of HPV?'; this question has been used previously [25]. After a brief description of the vaccine, vaccine status was assessed by asking participants to tick a box that best described them (response options: 'I have had all 3 doses of the HPV vaccine'; 'I have had 1 or 2 doses of the HPV vaccine'; 'I have been offered the HPV vaccine but I haven't had it'; 'I have not been offered the HPV vaccine'; 'I don't know'). "
    [Show abstract] [Hide abstract]
    ABSTRACT: A national school-based human papillomavirus (HPV) vaccination programme has been available for 12-13 year old females in the UK since 2008, offering protection against HPV types 16 and 18, which are responsible for the majority of cervical cancer. Little is known about HPV knowledge in girls who have been offered the vaccine. Girls offered the school-based vaccine in the first routine cohort (n=1033) were recruited from 13 schools in London three years post-vaccination. Participants completed a questionnaire about HPV awareness, knowledge about HPV and the vaccine, and demographic characteristics including vaccine status. About a fifth of the girls reported they were unaware of the HPV infection. Among those who reported being aware of HPV (n=759) knowledge was relatively low. Approximately half of the participants knew that HPV infection causes cervical cancer, condoms can reduce the risk of transmission and that cervical screening is needed regardless of vaccination status. These results are helpful in benchmarking HPV-related knowledge in vaccinated girls and could be used in the development of appropriate educational messages to accompany the first cervical screening invitation in this cohort in the future.
    Vaccine 12/2012; 31(7). DOI:10.1016/j.vaccine.2012.12.038 · 3.49 Impact Factor
Show more